FDA approves Novartis combo therapy for aggressive type of thyroid cancer
(Reuters) - The U.S. Food and Drug Administration on Friday approved Novartis AG's combination therapy to treat an aggressive type of thyroid cancer.
from Reuters: Health News https://reut.rs/2HRU2Mn
http://bit.ly/2zwRqiM